We have used a mouse model system and the corneal route of inoculation to examine the issue of extraneuronal persistence of herpes simplex virus type 1 (HSV-1). HSV-1 strain F DNA and inflammatory lesions were detected in corneal tissue of mice at 5, 11, 23, 37 and 60 days post-infection (p.i.). Viral DNA was localized by in situ PCR to epithelial cells and less frequently to cells in the stroma of the cornea. Viral proteins were not detected in the cornea and virus could not be isolated from tissue homogenates after 11 days p.i. even though histopathological lesions became progressively more severe at 37 and 60 days p.i. The DNA-containing cells were usually adjacent to the sites of inflammation or within these sites in the chronic stage (23, 37 and 60 days p.i.). In contrast to strain F, persistence of HSV-1 strain KOS DNA and inflammatory lesions were not detected after 11 days p.i. ; this result suggests that the long-term persistence of HSV-1 DNA and the development of inflammatory lesions are virus strain-dependent. We tested for the possibility of transgenic HSV-1 immediate early gene (ICP4) promoter activity in chronically infected corneas of transgenic mice containing the ICP4 promoter fused to the bacterial fl-galactosidase coding sequence. Our results indicated that the chimeric transgene was expressed in the cornea at 5, 11, 23, 37 and 41 days p.i. Possible explanations for these results and mechanisms for the generation of the chronic inflammatory lesions are discussed. The properties of chronic HSV infections in the cornea may be similar to those which have been described for persistent or defective viral infections in other systems.
Introduction
Herpes simplex virus type 1 (HSV-1) is known to cause latent infections of neurons (Stevens, 1975; Hill, 1985) in which gene expression is limited to the production of latency-associated transcripts (Deatley et at., 1987; Stevens et al., 1987; Wagner et al., 1988; Wechsler et al., 1988 ; Mitchell et al., 1990 b; Fraser et al., 1992) and lytic infections of a variety of tissues including epithelium and nervous system in which infectious virus is produced and all classes of viral genes are expressed (Roizman & Sears, 1990) . Less well understood is the role of HSV-1 in chronic inflammatory diseases which occur subsequent to acute HSV replication. For example, HSV-1 causes chronic corneal stromal keratitis in humans (Dawson et al., 1968; Whitley, 1985; Coupes et al., 1986; Cook & Hill, 1991) . Previous studies have reported the induction of stromal keratitis following corneal inoculation of HSV-1 in the rabbit and mouse (Metcalf et al., 1979; Wander et al., 1980; Tullo et al., 1982; Sabbaga et al., 1988; Shimeld et al., 1990; Mercadal et al., 1993) . The mechanism resulting in the inflammatory lesions has been shown to be immunopathological but the molecular details have not been characterized (Doymaz & Rouse, t992) . HSV-l-specific T lymphocytes contribute to the progression of herpetic stromal keratitis in mice (Newell et al., 1989; Mercadal et al., 1993) . These HSV-l-specific T lymphocytes recognize the immediate early proteins ICP4 and ICP27 but not ICP0 (Martin et al., 1990; Banks et al., 1991) . One possibility is that the virus may persist in some form with low-level expression of viral antigens in the cornea at the time of lesion formation and progression. The observation that naive as well as HSVspecific immune T lymphocytes could transfer the ability to produce corneal lesions to previously infected SCID mice (Mercadal et al., 1993) also could be consistent with the prolonged presence of viral target antigens in the cornea. Some support exists for the idea that HSV-1 can persist in a non-latent form for a long period of time. An HSV-1 mutant, in1814 (defect in the VP16 gene), has 0001-2226 © 1994 SGM been shown to produce a prolonged and productive infection in the nervous system of SCID mice (ValyiNagy et al., 1992) . A second possibility is that the virus infection could result in sensitization to a host antigen which could provide the target for immune cells.
The mouse corneal disease model is an example which can be exploited to gain insight into the broader question of whether HSV-1 can persist long term in non-neuronal cells and, if so, whether this non-neuronal infection is regulated in a way similar or different to latent HSV-1 infections of neurons. It seems reasonable to examine first the question of whether wild-type strains of HSV-1 can persist in non-neuronal cells of immune-competent mice. Several studies have reported that HSV can be isolated from skin or other peripheral tissue at the site of inoculation in mice and guinea-pigs at times long after inoculation (Scriba, 1977; Hill et al., 1980; A1-Saadi et al., 1988; Clements & Subak-Sharpe, 1988) ; in some of these experiments reactivation from the associated ganglia was excluded as a possible source of the isolated virus. Others have reported the isolation of infectious HSV and detection of viral antigen in corneas after immunosuppression and u.v. irradiation of mice infected chronically (Shimeld et al., 1990) and in the iris after explantation of the anterior segment of the eye of chronically infected mice (Claoud et al., 1990) .
Using techniques for the detection of DNA, proteins, infectious virus, lesions of HS¥ and transgenic immediate early gene (ICP4) promoter activity we have examined the issue of HSV-1 persistence and induction of disease in non-neural tissue. We have shown that HSV-I DNA persists in corneal cells in chronically infected mice and that viral DNA is spatially and temporally related to the progressive lesions. By using transgenic mice containing the immediate early promoter linked to the p-galactosidase reporter sequence we have also shown that the transgenic immediate early gene (ICP4) promoter is expressed in chronic corneal infections. Our observations are important for understanding the molecular mechanism of HSV-induced persistence and chronic inflammatory disease in the host and for designing therapeutic strategies. These findings have implications for HSV-induced chronic infections of nonneuronal cells in humans.
Methods
Animal infections. HSV-1 strains F and KOS were grown in Vero cells and virus stocks were prepared as previously described (Mitchell & Martin, 1992) . Mice were anaesthetized with methoxyftuorane and each cornea was scratched 10 times with a 26-gauge needle. Each animal received either 5 gl of MEM containing fetal calf serum or 5 pl of medium containing 107 p.f.u, of HSV-1 strain F or KOS on each cornea. Mouse strains included BALB/c, C57BL/6 x C3H and transgenic C57BL/6 x C3H (Tg6305) (W. J. Mitchell, unpublished data).
All except the transgenic mice were females 6 to 9 weeks of age; the transgenic mice and their littermate controls were males and females nearly all of which were 14 weeks old. The transgenic mice contained the ICP4 promoter (nucleotides -372 to +24 with respect to the transcriptional start site of ICP4) (Mackem & Roizman, 1982; McGeoch et al., 1986; Triezenberg et al., 1988) fused to the Escherichia coli fl-galactosidase coding sequence and including a simian virus 40 nuclear translocation signal (Mercer et al., 1991) . Heterozygous transgenic Tg6305 mice and control littermates were identified by polymerase chain reaction (PCR) using tail DNA and primers (5' GCATCGAGCTGGGTAATAAGCGTTGGCA-AT 3' and 5' GACACCAGACCAACTGGTAATGGTAGCGAC 3') for the fl-galactosidase sequence. Mice were killed at 5, 1 l, 23, 37, 60 or 120 days post-infection (p.i.) for analysis. The numbers of mice which were used in each experiment are listed in the tables and figure legends.
Analysis of DNA in tissue extracts. DNA samples were prepared from frozen corneas (Mitchell & Martin, 1992) or from paraffinembedded sections of cornea (Gressens et al., 1993) . Approximately 100 ng of DNA from frozen corneas was added to 200 laM each dNTP, 1.5 mM-MgCI~, 50 mM-KC1; 10 mM-Tris-HCl pH 8.3, 0-001% gelatin, 2-5 U of Taq polymerase and 100 ng of each primer and subjected to 30 cycles of PCR. Each cycle included 1 min at 94 °C, 2 min at 55 °C, and 3 min at 72 °C (Mitchell & Martin, 1992) . Oligonucleotide primers (5' ATCGTCTACGTACCCGAGCCGATGACTTAC 3' and 5' GG-CCTGGGGGGTCATGCTGCCCATAAGGTA 3") (McKnight, 1980) amplified a 327 bp fragment from the thymidine kinase (TK) gene of HSV-1. Ten ~tl of total DNA from deparaffinized and proteinase Kdigested samples were added to the reaction mixture and subjected to PCR as described above using oligonucleotide primers (5' TACCCG-AGCCGATGACTTAC Y and 5' GCGCTTGTCATTACCACCGC-3') (McKnight, 1980) which amplified a 130 bp fragment from the TK gene of HSV-1. In addition, primers (5' TCTCCATCCTATGTTGC-GGTCG 3' and 5' GGTTCACCATGTCTCCTCCAAGTAACTCG-G 3') specific for the mouse c-myc gene (Stanton et al., 1984) were included in the deparaffinized samples to verify that each sample contained similar amounts of DNA. The PCR bands were identified on Southern blots using oligonucleotide probes for the sequences bracketed by the primers: HSV-1 TK (Fig. 1 a) 5' CACCGCCTCGA-CCAGGGTGAGATATCGGCC 3', HSV-1 TK (Fig. I b) 5' TGGCG-GGTGCTGGGG 3' and mouse c-myc (Fig. 1 b) 5' GCAACTTCTCC-ACCGCCGAT 32
In situ polymerase chain reaction. Paraffin sections of corneas from HSV-l-infected and control mice were deparaffinized with xylene and ethanol. After heating of the slides to 82 °C for 2 min, the reaction mixture (also at 82 °C) was added and in situ PCR was performed for 15 cycles of 1 rain at 96 °C, 1 min at 59 °C and 1 min at 72 °C in a thermocycling oven (ISS) (Gressens & Martin, 1994) . The reaction mixture contained 10 ~t~-dATP, -dCTP and -dGTP, 3-5 gM-dTTP, 6-5 gM-digoxigenin-dUTP, 10% glycerol, 1.5 mM-MgCI 2, 2.5 U of native Taq polymerase, and 0-25 ~tM primers for the TK gene of HSV-1 (these are the same primers which were listed above; Fig. 1 b) . The slides were washed three times at room temperature in 10 mMTri~HC1 pH 8"3, 50 mM-KC1, 1.5 mM-MgC12 and 0.001% gelatin for 5min each, three times in 2x SSC-50% formamide at 37°C for I0 min each and twice at room temperature in 2 x SSC for 15 min each. The PCR product was visualized using alkaline phosphatase conjugated anti-digoxigenin antibody and an enzyme colour reaction as described in the Genius kit from Boehringer Mannheim. At least two sections were tested (including both corneas) from each of five mice from each time point in all groups except the 37 day p.i. KOS group (one set of sections was tested) and the 60 day p.i. F group (one set of sections from four mice was tested). In addition, in multiple examples serial sections were tested for labelling in the same location. As a negative control, primers for the vaccinia virus abortive late gene (5' AAA- Pacha et al., 1990) were substituted for the HSV-1 primers in selected sections adjacent to sections labelled for HSV-1 DNA. Uninfected mouse corneas were always tested with the HSV-1 primers in each group of slides. In acutely infected mice (5 days p.i.) adjacent sections were tested for HSV-I antigen by immunoperoxidase labelling and for HSV-1 DNA by in situ PCR.
Histopathology and immunocytochemistry.
Sections from the same eyes that were assayed for HSV-1 DNA were evaluated for lesions and for the presence of viral antigen. Haematoxylin-and eosin-stained corneas were evaluated by light microscopy for the presence of lesions and the thickness of individual corneas was measured at the thickest point using a scale in the eyepiece. For viral antigen, deparaffinized sections were labelled by the avidin-biotin-peroxidase method (Vector) using HSV-1 antiserum (Dako) at a 1:1000 dilution (Mitchell & Martin, 1992) . As controls, uninfected mouse corneas were reacted with the HSV-1 antiserum and infected corneas were reacted with control rabbit serum in the same assays.
Virus isolation. After corneal inoculation, mice were killed at 5, 11, 23, 37 or 60 days p.i. and eyes were removed. For direct isolation, whole eyes were homogenized and the total homogenate (all groups 11, 23 and 37 days p.i.) was assayed on Vero cells overlaid with methyl cellulose in a standard plaque assay. Direct isolation at 5 days p.i. was performed on 10-fold dilutions starting with 10% of the total homogenates. For explantation, eyes were divided into cornea and remaining eye and each individual sample was placed in a single well of a six-well plate containing medium and an indicator layer of Vero cells. In addition, both ganglia from each animal were also assayed by this method as a positive control (Mitchell et al., 1990 a) . Explanted tissues were maintained for 21 days and monitored daily for cytopathic effects in the indicator cells• Samples were changed to fresh indicator cells every 4 to 5 days.
Beta-galactosidase assays. Transgenic (Tg6305) mice containing the ICP4 promoter of HSV-1 fused to the fl-galactosidase coding sequence were either inoculated on each cornea with 107 p.f.u, of HSV-1 F or mock-inoculated. Control non-transgenic mice were inoculated with 107-p.f.u. of HSV-1 F. In addition, mock-inoculated non-transgenic mice were included in one experiment as controls (Table 3) . Groups of Tg6305 and control animals were killed at the times post-infection or post mock-inoculation which are listed in Table 3 . At least four animals (eight corneas) were in each group at 5, 11, 23 and 37 days after experimental manipulation. Tissues from Tg6305 and control nontransgenic mice were dissected, snap-frozen and stored at -7 0 °C. Enzymatic assays for fl-galactosidase were performed by a modification of a previously described method (Sanes et al., 1986) . Frozen eyes were fixed immediately in cold 4% paraformaldehyde for 30 min and washed in PBS for 5 min. Eyes were then incubated for 14 to 18 h in the substrate solution at 37 °C. The substrate solution contained 20 mMpotassium ferrocyanide, 20 m,'~-potassium ferricyanide, 2 m~-MgC12, 1 mg per ml X-Gal and 120 ~1 of 10% NP40 and 200 lal of 1% sodium deoxycholate per 20 ml. After washing in PBS for 5 min, corneas were placed on slides as whole mounts in PBS and evaluated by light microscopy.
Results

Clinical signs in BALB/c and C57BL/6 × C3H mice inoculated with HSV-1 F or KOS
Although detailed eye examinations were not recorded for the mice in these experiments, in general, progressive corneal opacification developed in BALB/c mice inoculated with HSV-1 strain F beginning at approximately 3 weeks after inoculation. BALB/c mice inoculated with strain KOS showed little or no evidence of corneal opacity. The C57BL/6 x C3H mice inoculated with strain F showed evidence of corneal opacities to a lesser degree than the strain F-inoculated BALB/c mice. Mortality was not observed as a consequence of infection with either HSV-1 F or KOS in these experiments.
HSV-1 strain F DNA in non-neural tissue of chronically infected BALB/c mice
The 327bp fragment of the HSV-1 TK gene was amplified by PCR in samples of corneas from HSV-1 Finoculated BALB/c mice at 5, 11, 37 and 60 days p.i. (Fig. 1 a, lanes 6 to 10) . Each test sample included pooled DNA from three mice. No TK fragment was amplified from uninfected corneas in the same experiments ( 
Histopathological lesions and viral antigen distribution in B A L B / c mice infected with HSV-1 F
The lesions at 5 days p.i. corresponded, but were not confined to, the areas of the cornea in which viral antigens were detected. These lesions consisted of focally extensive accumulations of neutrophils and oedema in multifocal areas within the stroma. Overlying the stromal lesions, the epithelial cells often showed necrosis and viral antigen labelling (Fig. 2a) . Viral antigen was also occasionally detected in cells within the stroma. The majority of BALB/c mice infected with HSV-1 F were positive for viral antigen in the cornea at 5 days p.i. ( I Measurements are all in micrometres and were all made at the thickest portion of each 7 gm haematoxylin-and eosin-stained corneal section.
M is the mean thickness of 10 corneas in each group. 4a). However, no viral antigen was detected in the cornea at 11, 23, 37 or 60 days p.i. (Fig. 4a) . At later times post-infection with strain F (11, 23, 37 and 60 days) lesions were present in most of the animals (Fig. 4 a) and were multifocal or diffuse and often severe. These corneal lesions were histologically classified as chronic active and evidence of chronicity as well as acute activity was present. In addition, lesions at 23 and 37 days p.i. were usually more severe than those at 5 and 11 days p.i. The thickness of the corneas was increased at 23, 37 and 60 days p.i. reflecting the increase in inflammation and stromal and epithelial hyperplasia (Table 1 ). In the stroma, these lesions were characterized by a diffuse infiltration of neutrophils, macrophages and lymphocytes, oedema and neovascularization ( Fig. 3c  and g ). The corneal epithelium was often hyperplastic and contained focal areas of necrosis and infiltrates of neutrophils ( Fig. 3 c and g ). Occasionally, keratinization and goblet cell metaplasia were present in the epithelium (data not shown).
HSV-1 F DNA was localized predominantly to epithelial cell nuclei and was related in location to chronic progressive lesions
The HSV-1 TK primers which were used for in situ PCR detected the 130 bp TK fragment but did not amplify DNA from control corneas even though the mouse cmyc fragment was amplified in controls as well as virusinfected samples (Fig. l b, lanes 5 to 11) . These TK primers were used in in situ PCR to show that in serial sections of acutely infected corneas viral DNA was located in areas corresponding to the areas of viral antigen labelling ( Fig. 2a and b) . The in situ P C R assay did not label any cells in uninfected corneas (Fig. 2c) . HSV-1 F D N A was detected by in situ P C R in 10 of 10, eight of 10, nine of 10 and nine of 10 corneas tested at 5, 11, 23 and 37 days p.i., respectively (Fig. 4a) . In addition three of eight corneas were positive for HSV-1 D N A at 60 days p.i. and one of six was positive at 120 days p.i. Consecutive serial sections tested with HSV-1 T K primers showed positive labelling in the same foci (Fig.  3 a and b ). Sections that were tested with vaccinia virus abortive late gene primers failed to show any labelling even though the adjacent section was positive for HSV-1 in the same assay when tested with the HSV-1 T K primers ( Fig. 3d and f ) . In most cases, the labelled cells were epithelial (Fig. 3a, b, d and e) and the reaction product was localized predominantly in nuclei of the positive cells (Fig. 3 e) . The labelled epithelial cells were usually adjacent to stromal inflammation (Fig. 3 c and g ) and often these cells were associated with abnormalities in the epithelium such as hyperplasia, necrosis and inflammation (Fig. 3 c and g ). In addition, labelled cells were observed occasionally in the stroma of chronically infected corneas and these were also usually related to inflammation.
Apparent absence of infectious virus in non-neural tissue of chronically infected B A L B / c mice
N o virus was detected in homogenates of 10 eyes each from HSV-1 F-infected B A L B / c mice at 23 and 37 days p.i. (Table 2 , Experiment 1), HSV-1 was detected in 10 of 10 similarly infected corneas at 5 days p.i, and six of 10 at 11 days p.i. N o virus was detected in six explanted I Numerator is number of samples positive for infectious virus, denominator is total number of samples tested.
Isolation of infectious HSVol from cornea or eyes and ganglia of mice by either homogenization and direct isolation of virus (lytic virus infection) or explantation of tissue and isolation of virus (latent virus infection)
ND, not done.
corneas each at 11, 23, 37 and 60 days p.i. (Table 2 , Experiment 2). All explanted ganglia from the same mice were positive for virus (Table 2 , Experiment 2).
Induction of chronic progressive lesions and long term presence of HSV-I DNA varies with the virus strain
In contrast to HSV-1 F, KOS infection resulted in corneal lesions in one of 10 corneas at 11 days p.i. and none of 10 each at 23 and 37 days p.i. (Fig. 4b) . The same cornea which contained a lesion at 11 days p.i. was positive for HSV-1 KOS DNA by in situ PCR. Viral DNA was present in the epithelium and was adjacent to the lesion. All other corneas at 11, 23 and 37 days p.i. were negative for HSV-1 KOS DNA (Fig. 4b) . The absence of KOS DNA and virus-induced inflammation at 23 and 37 days p.i. was reflected by corneal thickness measurements which were approximately equal to those of controls (Table 1) . At 5 days p.i. five of 14 corneas were positive for HSV-1 DNA and six of 14 were positive for viral antigen in HSV-1 KOS-infected mice. Ten of 14 of these mice showed viral DNA labelling in extraocular tissues (conjunctiva or eyelid) which were present on the same slides as the corneas. The mean of the log10 of the virus titres of 10 KOS-infected eyes at 5 days p.i. was 4-4 whereas the mean of the log10 of the titres of 10 Finfected eyes at 5 days p.i. was 4.0. Thus even though fewer corneas were positive for viral DNA at 5 days in KOS-infected mice, the presence of the virus in other related structures and isolation of virus from the eyes ( Table 2 , Experiment 3) verify that the majority of mice became infected and acute phase viral replication was similar to that observed with strain F. It appears that the KOS strain is not able to persist efficiently in the cornea. The fact that these same animals did not develop corneal lesions would further suggest that HSV-1 persistence in the cornea is required to induce the chronic corneal lesions.
Transgenic ICP4 promoter activity is present in corneal cells of chronically infected mice
We next evaluated whether a transgenic HSV-1 immediate early (ICP4) gene promoter is activated in these chronic corneal infections. This approach does not prove that the viral ICP4 gene is being expressed; however, in the absence of evidence of HSV-1 gene expression, these experiments provide information that raises this possibility. We first tested C57BL/6 x C3H mice (the genetic background of the Tg6305 transgenic mice) to verify that HSV-1 DNA persists and that lesions occur. Viral antigen was detected in six of 10 corneas of HSV-1 Finfected non-transgenic C57BL/6 x C3H mice at 5 days p.i. ; viral protein was not detected in 10 corneas each at 11, 23 or 37 days p.i. Viral DNA was detected in three of 10 corneas at 5 days, five of 10 corneas at 11 days, and one of 10 corneas at 23 days. Lesions were detected in 10 of 10, nine of 10, eight of 10 and six of 10 corneas at 5, 11, 23 and 37 days p.i., respectively. Infectious virus was detected from 10 of 10 eye homogenates at 5 days p.i.; however, no infectious virus was detected from 10 eyes each at 11, 23 and 37 days p.i. in this mouse strain (Table lOO   ~ 2, Experiment 5). Virus was detected in one of eight explanted corneas at 23 days p.i. but no virus was detected in eight corneas each at 37 and 60 days p.i. (Table 2 , Experiment 6). As in BALB/c mice, the majority of ganglia from the same mice yielded virus from explants. The model of viral DNA persistence and chronic lesions after HSV-1 infection was verified in the more resistant transgenic mouse strain.
fl-Galactosidase-positive cells were detected in the corneas of HSV-l-infected Tg6305 mice at 5, 11, 23 and 37 days p.i. (Fig. 5a to e and Table 3 ). Owing to the thickness of the corneal whole mounts, identification of the labelled cell type was not possible. All mock-infected Tg6305 corneas were negative at 5, 11, 23 and 37 days post mock-inoculation ( Fig. 5fand Table 3 ). All corneas of HSV-1 F-infected non-transgenic mice were negative for fl-galactosidase labelling (Table 3) . In a separate experiment (Table 3) , fl-galactosidase-positive cells were detected in the corneas of Tg6305 mice at 41 days p.i. Tg6305 mice (mock-inoculated) and non-transgenic controls (both virus-infected and mock-inoculated) were negative when their corneas were tested by the fl-galactosidase assay at 5 days post-manipulation (Table 3) .
Discussion
In this report we have examined the fate of chronic HSV-1 infections of non-neuronal cells in vivo. Particularly important is the property of these infections to produce chronic inflammatory lesions. It is possible that persistent HSV infections of cells other than neurons could be a mechanism for generating inflammatory lesions in structures of the eye and the nervous system. Chronic inflammatory lesions following HSV-1 inoculation have been previously reported in the cornea of mice and rabbits (Wander et al., 1980; Sabbaga et al., 1988) . To the best of our knowledge, the present study represents the first time that HSV-1 DNA has been localized during chronic infections using the highly sensitive method of in situ PCR. This technique has allowed us not only to localize the HSV-1 DNA to specific cells within the cornea, but also to compare the ability of two different viral strains to persist in corneal cells. It has been previously reported that HSV-l-hybridizing sequences were present in chronically infected rabbit corneas (Sabbaga et al., 1988) ; that study used a standard in situ hybridization method. Solution-phase PCR has been used to demonstrate HSV DNA in tissue extracts of chronically infected corneas of humans (Crouse et al., 1990; Cantin et al., 1991) .
There are several possible mechanisms by which HSV-1 could cause chronic progressive lesions in the cornea. First, the virus could persist in cells and produce a low level of viral antigens from some or all of its genes over a long period. These viral proteins could stimulate the immune response and result in inflammation. Second, the viral infection could result in sensitization to a hostcell antigen which could then drive the inflammatory process. Third, the virus could reactivate periodically from the ganglia and initiate a lytic infection with viral antigen in the cornea which could lead to inflammation. Our studies, using the in situ PCR assay, show that HSV-1 F DNA is present in most corneas of BALB/c mice at 5, 11, 23, 37 and 60 days p.i. The viral DNA was localized most often to epithelial cells and was usually closely related to stromal and epithelial lesions. In contrast, the KOS strain of HSV-1 is inefficient in producing chronic lesions and viral DNA does not persist after 11 days p.i. In corneal infections with each HSV-1 strain there was apparently a relationship between the localization ofHSV-1 DNA and the presence of chronic lesions. The detection of HSV-1 DNA throughout the time course which we studied and in the appropriate location in chronically infected corneas suggests that persistence of viral DNA is a requirement for the initiation of the inflammatory response. If the HSV-1 D N A detected in the majority of corneas in our study resulted from a reactivated and lytic infection in the epithelium we would expect to be able to isolate infectious virus. However, infectious virus was not isolated from homogenates of any corneas after 11 days p.i. or any ganglia after 5 days. Therefore it appears unlikely that a reactivated and lyric infection is the underlying mechanism by which chronic corneal inflammation proceeds.
With the virus and mouse strains used in our study, isolation of virus from chronically infected explanted corneas was rare (one of 58 in our study), even though virus was isolated from a high percentage of ganglia after explantation (53 of 58 in our study). The presence of a persistent viral infection in the cornea would not preclude occasional isolation of virus from explanted corneas. It is possible that HSV-1 D N A persists in corneal cells and induces inflammation by an immune mechanism after expressing some or all of the viral genes. It is also possible that persistent infection of stromal cells, although less often observed in our studies, may contribute to the development of lesions by the production of inflammatory mediators (Oakes et al., 1993) . T lymphocytes are the primary immune cells responsible for producing inflammation in HS¥-1-infected corneas (Metcalf et al., 1979; Mercadal et al., 1993) . Immediate early proteins are among the HSV-1 proteins which are antigenic targets for these T lymphocytes; specificalIy immediate early proteins ICP4 and ICP27 but not ICP0 are recognized (Martin et al., 1990; Banks et al., 1991) . HSV-1 immediate early gene expression might occur in chronically infected corneas and therefore these proteins could serve as the link between the presence of viral DNA, immune cells and progressive disease. Mice containing the HSV-1 ICP4 promoter linked tq the fl-galactosidase coding sequence (Tg6305) exhibited transgenic immediate early gene promoter activity in chronically infected corneas. It is. possible that host proteins may activate the transgenic ICP4 promoter by a mechanism which is independent of gene expression from persisting viral genomes. In light of the progressive disease and persistence of the viral genome, it may be likely that the ICP4-fl-galactosidase reporter transgene expression is related to viral gene expression in these chronically infected corneas. It will be important to determine whether the presence of the activated reporter transgene in chronically infected corneas is related to gene expression from persistent viral genomes. Experiments employing very sensitive techniques for detectingviral RNA and viral proteins will be required to resolve this issue of HSV-1 gene expression in persistently infected corneal cells. One possible explanation for our observations and those of others is that HSV-1 can persist in non-neuronal cells for an indefinite period with some gene expression and initiate chronic inflammatory lesions. It will be interesting to determine whether and to what extent viral gene expression occurs in chronically infected non-neuronal cells and to determine whether non-neuronal cells within the nervous system behave in a way similar to corneal cells after long-term infection.
